As
demand increases for better ways to develop, control and manufacture
biologics and biosimilars, Spinnovation Biologics has developed three
different options for accessing its services for biologics production: Pay
per Sample, Contract Analysis and Custom Services. All are designed to
provide clients with the most efficient and appropriate access to
Spinnovation Biologics' fast (from 5 working days), detailed and
cost-effective bioanalysis services, according to their own specific
requirements. Spinnovation
Biologics provides a unique mix of services for spent culture media
analysis, as well as the profiling and characterization of biologics and
biosimilars, delivering essential support for the development and
manufacture of biologics.
Pay-Per-Sample
is a flexible format that allows clients to choose the number of
samples and type of analytes to be analyzed, matching with their budget,
with the facility to request a quote via the Spinnovation Biologics
website. Contract Analysis is designed for large sample numbers -
multiple projects or multi-centre studies for example - where
Spinnovation Biologics will provide a global offer based on the size of
the project. Custom Services offer a tailored analytical approach that
addresses specific issues in a biologics development or manufacturing
program, with the Spinnovation team providing specialist advice and
help.
"As
the development of new biologics therapies and biosimilars increases,
we're seeing a growing demand for rapid, high throughput bioanalysis
methods that provide critical insights into how cell production systems
are behaving, and how to optimize and control production while insuring
quality and re-enforcing safety." said Frederic Girard CEO and
co-founder of Spinnovation Biologics. "Because our NMR-based spent media
technology can perform in fast-throughput mode (over 100 samples/day)
and analyze over 40 media components at a time, it is drawing massive
interest from specialists in this area, removing prior limitations
(time, level of details). Our service options have been tailored such
that we can respond to small academic research projects up to pilot
production for biotech and biopharma."
Spinnovation's
proprietary NMR platform, Spedia-NMR
TM and its large portfolio of
analytical technology help in fully understanding and controlling cell
growth conditions from the very earliest stages of cell line
development, to effectively optimise protein production. The unique
Spedia-NMR
TM platform allows Spinnovation Biologics to deliver cell
culture analysis data within five working days of sample receipt
whichever service option is selected.
For further information, please visit:
www.spinnovation-biologics.com Spedia-NMRTM is a registered trademark of Spinnovation Analytical BV
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.